These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10889791)

  • 1. Genetics of the metabolic syndrome.
    Groop L
    Br J Nutr; 2000 Mar; 83 Suppl 1():S39-48. PubMed ID: 10889791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic susceptibility to diabetes and hypertension].
    Ikegami H; Ogihara T
    Nihon Rinsho; 2003 Jul; 61(7):1105-12. PubMed ID: 12877070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dysmetabolic syndrome.
    Groop L; Orho-Melander M
    J Intern Med; 2001 Aug; 250(2):105-20. PubMed ID: 11489060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and beta 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Prospective Diabetes Study.
    Zhang Y; Wat N; Stratton IM; Warren-Perry MG; Orho M; Groop L; Turner RC
    Diabetologia; 1996 Dec; 39(12):1505-11. PubMed ID: 8960833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance: the fundamental trigger of type 2 diabetes.
    Groop LC
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S1-7. PubMed ID: 11220283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic factors and insulin resistance].
    Yamada Y; Seino Y
    Nihon Rinsho; 2000 Feb; 58(2):315-9. PubMed ID: 10707551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of candidate genes in Polish families with obesity.
    Malczewska-Malec M; Wybranska I; Leszczynska-Golabek I; Partyka L; Hartwich J; Jabrocka A; Kiec-Wilk B; Kwasniak M; Motyka M; Dembinska-Kiec A
    Clin Chem Lab Med; 2004 May; 42(5):487-93. PubMed ID: 15202783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of visceral obesity and insulin resistance: relationship to non-insulin-dependent diabetes mellitus.
    Groop L
    Growth Horm IGF Res; 1998 Apr; 8 Suppl B():9-14. PubMed ID: 10990130
    [No Abstract]   [Full Text] [Related]  

  • 10. The molecular genetics of non-insulin-dependent diabetes mellitus.
    Groop LC
    J Intern Med; 1997 Feb; 241(2):95-101. PubMed ID: 9077364
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity.
    San Millán JL; Cortón M; Villuendas G; Sancho J; Peral B; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2640-6. PubMed ID: 15181035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of type 2 diabetes and insulin resistance: knowledge from human studies.
    McIntyre EA; Walker M
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):303-11. PubMed ID: 12201821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion.
    Groop L
    Int J Clin Pract Suppl; 2000 Oct; (113):3-13. PubMed ID: 11965829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathology in the obese spontaneous hypertensive Koletsky rat: a model of syndrome X.
    Ernsberger P; Koletsky RJ; Friedman JE
    Ann N Y Acad Sci; 1999 Nov; 892():272-88. PubMed ID: 10842668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy.
    Catalano PM; Nizielski SE; Shao J; Preston L; Qiao L; Friedman JE
    Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E522-33. PubMed ID: 11832353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin resistance and metabolic syndrome].
    Joost HG; Giesen K; Kluge R; Ortlepp J; Plum L
    Z Kardiol; 2000 May; 89(5):377-82. PubMed ID: 10900666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic use of gene polymorphism for type 2 diabetes].
    Sanke T
    Rinsho Byori; 2002 Sep; 50(9):871-6. PubMed ID: 12386964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The silent PPARgamma exon 6 CAC(His) --> CAT(His) polymorphism does not affect the plasma leptin levels in a collective of first degree relatives of type 2 diabetes patients from South West Germany.
    Koch M; Rett K; Maerker E; Volk A; Haist K; Deninger M; Rettig A; Renn W; Häring HU
    Exp Clin Endocrinol Diabetes; 2000; 108(5):341-6. PubMed ID: 10989952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of insulin resistance.
    Mercado MM; McLenithan JC; Silver KD; Shuldiner AR
    Curr Diab Rep; 2002 Feb; 2(1):83-95. PubMed ID: 12643127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depot-specific differences in adipose tissue gene expression in lean and obese subjects.
    Lefebvre AM; Laville M; Vega N; Riou JP; van Gaal L; Auwerx J; Vidal H
    Diabetes; 1998 Jan; 47(1):98-103. PubMed ID: 9421381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.